Pfizer drug effective in small breast cancer study (Reuters


Reuters - Pfizer Inc.'s experimental cancer
drug Sutent shrank tumors in 14 percent of patients with
advanced breast cancer, according to early results from a
mid-stage trial presented on Monday.

Read more...